Microsatellite Instability in Colorectal Cancer

Boland, C. Richard, Goel, Ajay·2010·Gastroenterology

DOI 10.1053/j.gastro.2009.12.064

Cited by (1,002)

Items 201–300 of 1,002

Immune Activation in Mismatch Repair–Deficient Carcinogenesis: More Than Just Mutational Rate
Jason A. Willis, Laura Reyes-Uribe, Kyle Chang, Steven M. Lipkin, Eduardo Vilar · 2019 · Clinical Cancer Research
Challenges and Therapeutic Opportunities in the dMMR/MSI-H Colorectal Cancer Landscape
Núria Mulet-Margalef, Jenniffer Linares, Jordi Badia-Ramentol, Mireya Jimeno, Carolina Sanz, José Luis Manzano Mozo, Alexandre Calon · 2023 · Cancers
MicroRNAs as growth regulators, their function and biomarker status in colorectal cancer
Lina Cekaite, Peter W. Eide, Guro Elisabeth Lind, Rolf Inge Skotheim, Ragnhild A. Lothe · 2015 · Oncotarget
Molecular and prognostic heterogeneity of microsatellite-unstable colorectal cancer
Jung Ho Kim · 2014 · World Journal of Gastroenterology
NFE2L2 Is a Potential Prognostic Biomarker and Is Correlated with Immune Infiltration in Brain Lower Grade Glioma: A Pan-Cancer Analysis
Qiang Ju, Xinmei Li, Heng Zhang, Songxia Yan, Ying Li, Yanjie Zhao · 2020 · Oxidative Medicine and Cellular Longevity
The diapause-like colorectal cancer cells induced by SMC4 attenuation are characterized by low proliferation and chemotherapy insensitivity
Xuedan Sun, Lifang He, Hong Liu, Rick Francis Thorne, Taofei Zeng, Liu Liu, Bo Zhang, Miao He, Yabin Huang, Mingyue Li et al. · 2023 · Cell Metabolism
Insight into Mucinous Colorectal Carcinoma: Clues from Etiology
Niek Hugen, Jasper J. P. van Beek, Johannes H.W. de Wilt, Irıs D. Nagtegaal · 2014 · Annals of Surgical Oncology
Molecular Events in Primary and Metastatic Colorectal Carcinoma: A Review
Rani Kanthan, Jenna‐Lynn B. Senger, Selliah Chandra Kanthan · 2012 · Pathology Research International
Molecular Subtypes of Colorectal Cancer and Their Clinicopathologic Features, With an Emphasis on the Serrated Neoplasia Pathway
Jeong Mo Bae, Jung Ho Kim, Gyeong Hoon Kang · 2016 · Archives of Pathology & Laboratory Medicine
EMAST is a Form of Microsatellite Instability That is Initiated by Inflammation and Modulates Colorectal Cancer Progression
John M. Carethers, Minoru Koi, Stephanie S. Tseng-Rogenski · 2015 · Genes
Clinical problems of colorectal cancer and endometrial cancer cases with unknown cause of tumor mismatch repair deficiency (suspected Lynch syndrome)
Aung Ko Win, Daniel D. Buchanan, Christophe Rosty, Mark Clendenning, Amanda B. Spurdle · 2014 · The Application of Clinical Genetics
Interleukin 6 Alters Localization of hMSH3, Leading to DNA Mismatch Repair Defects in Colorectal Cancer Cells
Stephanie S. Tseng-Rogenski, Yasushi Hamaya, Daniel H. Choi, John M. Carethers · 2014 · Gastroenterology
A Let-7 MicroRNA SNP in the KRAS 3′UTR Is Prognostic in Early-Stage Colorectal Cancer
Kim M. Smits, Trupti Paranjape, Sunitha V. Nallur, Kim A.D. Wouters, Matty P. Weijenberg, Leo J. Schouten, Piet A. van den Brandt, Fred T. Bosman, Joanne Barnes Weidhaas, Manon van Engeland · 2011 · Clinical Cancer Research
Prognostic Significance and Molecular Associations of Tumor Growth Pattern in Colorectal Cancer
Teppei Morikawa, Aya Kuchiba, Zhi Rong Qian, Mari A. Mino-Kenudson, Jason L. Hornick, Mai Yamauchi, Yu Imamura, Xiaoyun Liao, Reiko Nishihara, Jeffrey A. Meyerhardt et al. · 2011 · Annals of Surgical Oncology
Pre-treatment CT-based radiomics nomogram for predicting microsatellite instability status in colorectal cancer
Qian Pei, Xiaoping Yi, Chen Chen, Peipei Pang, Yan Hong Huang Fu, Guangwu Lei, Changyong Chen, Fengbo Tan, Guanghui Gong, Qingling Li et al. · 2021 · European Radiology
The detective, prognostic, and predictive value of DNA methylation in human esophageal squamous cell carcinoma
Kai Ma, Baoping Cao, Mingzhou Guo · 2016 · Clinical Epigenetics
Targeted Sequencing of Cancer-Related Genes in Colorectal Cancer Using Next-Generation Sequencing
Sae‐Won Han, Hwang‐Phill Kim, Jong-Yeon Shin, Eun-Goo Jeong, Won‐Chul Lee, Kyung-Hun Lee, Jae‐Kyung Won, Tae‐Yong Kim, Do‐Youn Oh, Seock‐Ah Im et al. · 2013 · PLoS ONE
Noninvasive Biomarkers of Colorectal Cancer: Role in Diagnosis and Personalised Treatment Perspectives
Gianluca Pellino, Gaetano Gallo, Pierlorenzo Pallante, Raffaella Capasso, Alfonso De Stefano, Isacco Maretto, Umberto Malapelle, Shengyang Qiu, Stella Nikolaou, Andrea Barina et al. · 2018 · Gastroenterology Research and Practice
A practical guide to biomarkers for the evaluation of colorectal cancer
Wei Chen, Wendy L. Frankel · 2018 · Modern Pathology
Genetic and genomic basis of the mismatch repair system involved in Lynch syndrome
Kazuo Tamura, Motohide Kaneda, Mashu Futagawa, Miho Takeshita, Sanghyuk Kim, Mina Nakama, Norihito Kawashita, Junko Tatsumi‐Miyajima · 2019 · International Journal of Clinical Oncology
MSI/MMR-deficient tumor diagnosis: Which standard for screening and for diagnosis? Diagnostic modalities for the colon and other sites: Differences between tumors
Svrcek, Magali, Lascols, Olivier, Cohen, Romain, Collura, Ada, Jonchère, Vincent, Fléjou, Jean-François, Buhard, Olivier, Duval, Alex · 2019 · Bulletin du Cancer
DNA methylation biomarkers as diagnostic and prognostic tools in colorectal cancer
Melina-Theoni Gyparaki, Efthimia K. Basdra, Athanasios G. Papavassiliou · 2013 · Journal of Molecular Medicine
Genomic signatures reveal DNA damage response deficiency in colorectal cancer brain metastases
Jing Sun, Cheng Wang, Yi Zhang, Lingyan Xu, Weijia Jia Fang, Yuping Zhu, Yi Zheng, Xiaofeng Chen, Xiju Xie, Xinhua Hu et al. · 2019 · Nature Communications
Retrotransposon insertions can initiate colorectal cancer and are associated with poor survival
Tatiana Cajuso, Päivi Sulo, Tomas J. Tanskanen, Riku Katainen, Aurora Taira, Ulrika A. Hänninen, Johanna Kondelin, Linda M. Forsström, Niko Välimäki, Mervi Aavikko et al. · 2019 · Nature Communications
High Lymph Node Yield is Related to Microsatellite Instability in Colon Cancer
Eric J.T. Belt, E. A. te Velde, Oscar Krijgsman, Rebecca P. M. Brosens, Marianne Tijssen, Hendrik F HFvE Van Essen, Hein B.A.C. Stockmann, Herman Bril, Beatriz G. Carvalho, Bauke Ylstra et al. · 2011 · Annals of Surgical Oncology
Proteomics in colorectal cancer translational research: Biomarker discovery for clinical applications
Meike de Wit, Remond J.A. Fijneman, Henk M.W. Verheul, Gerrit A. Meijer, Connie R. Jiménez · 2012 · Clinical Biochemistry
Loss of CDX2/CK20 Expression Is Associated With Poorly Differentiated Carcinoma, the CpG Island Methylator Phenotype, and Adverse Prognosis in Microsatellite-unstable Colorectal Cancer
Jung Ho Kim, Ye-Young Rhee, Jeong Mo Bae, Nam‐Yun Cho, Gyeong Hoon Kang · 2013 · The American Journal of Surgical Pathology
The clinical value of aberrant epigenetic changes of DNA damage repair genes in human cancer
Dan Gao, James Gordon Herman, Mingzhou Guo · 2016 · Oncotarget
A novel classification of colorectal tumors based on microsatellite instability, the CpG island methylator phenotype and chromosomal instability: implications for prognosis
Colinda C.J.M. Simons, Laura Hughes, Kim M. Smits, Carolina A.J. Khalid-de Bakker, Adriaan P. De Bruïne A, Beatriz G. Carvalho, Gerrit A. Meijer, Leo J. Schouten, Piet A. van den Brandt, Matty P. Weijenberg et al. · 2013 · Annals of Oncology
Colonic Lysine Homocysteinylation Induced by High-Fat Diet Suppresses DNA Damage Repair
Dan Wang, Rui Zhao, Yuanyuan Qu, Xinyu Mei, Xuan Zhang, Qian Zhou, Yang Li, Shaobo Yang, Zhigui Zuo, Yi‐Ming Chen et al. · 2018 · Cell Reports
Microbiota impact on the epigenetic regulation of colorectal cancer
Yang, Tao, Owen, Jennifer L., Lightfoot, Yaíma L., Kladde, Michael P., Mohamadzadeh, Mansour · 2013 · Trends in Molecular Medicine
Analyzing and validating the prognostic value and mechanism of colon cancer immune microenvironment
Xinyi Wang, Jinzhong Duanmu, Xiaorui Fu, Taiyuan Li, Qunguang Jiang · 2020 · Journal of Translational Medicine
Cancer-associated fibroblasts undergoing neoadjuvant chemotherapy suppress rectal cancer revealed by single-cell and spatial transcriptomics
Pengfei Qin, Huaxian Chen, Yuhang Wang, Liang Huang, Ke Huang, Guozhong Xiao, Changpeng Han, Jiancong Hu, Dezheng Lin, Xingyang Wan et al. · 2023 · Cell Reports Medicine
Truncating mutation in the autophagy gene UVRAG confers oncogenic properties and chemosensitivity in colorectal cancers
Shanshan He, Zhen Zhao, Yongfei Yang, Douglas O’Connell, Xiaowei Zhang, Soohwan Oh, Binyun Ma, Joo-Hyung Lee, Tian Zhang, Bino Abel Varghese et al. · 2015 · Nature Communications
Opportunities for immunotherapy in microsatellite instable colorectal cancer
Harm Westdorp, Felix L. Fennemann, Robbert D.A. Weren, Tanya M. Bisseling, Marjolijn J. L. Ligtenberg, Carl Gustav Figdor, Gerty Schreibelt, Nicoline Hoogerbrugge, Florian Wimmers, I. Jolanda M. de Vries · 2016 · Cancer Immunology Immunotherapy
Identifying mismatch repair‐deficient colon cancer: near‐perfect concordance between immunohistochemistry and microsatellite instability testing in a large, population‐based series
Maurice Bernard Loughrey, Jason McGrath, Helen G. Coleman, Peter Bankhead, Perry Maxwell, Claire McGready, Victoria Bingham, Matthew P. Humphries, Stephanie G. Craig, Stephen McQuaid et al. · 2020 · Histopathology
Immune escape and resistance to immunotherapy in mismatch repair deficient tumors
Guillaume Mestrallet, Matthew Brown, Cansu Cimen Bozkus, Nina Bhardwaj · 2023 · Frontiers in Immunology
The molecular background of mucinous carcinoma beyond MUC2
Niek Hugen, Michiel Simons, Altuna Halilović, Rachel S. van der Post, Anna J. Bogers, Monica Marijinissen Van Zanten, Johannes H.W. de Wilt, Irıs D. Nagtegaal · 2014 · The Journal of Pathology Clinical Research
Prognostic value of HLA class I, HLA-E, HLA-G and Tregs in rectal cancer: a retrospective cohort study
Marlies S. Reimers, Charla C. Engels, Hein Putter, Hans Morreau, Gerrit‐Jan Liefers, Cornelis JH van de Velde, Peter J.K. Kuppen · 2014 · BMC Cancer
Suppressing neutrophil-dependent angiogenesis abrogates resistance to anti-VEGF antibody in a genetic model of colorectal cancer
Yoshiro Itatani, Takamasa S. Yamamoto, Cuiling Zhong, Alfredo Molinolo, Jane Ruppel, Priti S. Hegde, Makoto Mark Taketo, Napoleone Ferrara · 2020 · Proceedings of the National Academy of Sciences
Prognostic value and immunological role of PDCD1 gene in pan-cancer
Yandong Miao, Jiangtao Wang, Qiutian Li, Wuxia Quan, Yingying Wang, Chen Li, Jingjing Wu, Denghai Mi · 2020 · International Immunopharmacology
Colorectal Cancer-Associated Immune Exhaustion Involves T and B Lymphocytes and Conventional NK Cells and Correlates With a Shorter Overall Survival
Carlo Sorrentino, Luigi D’Antonio, Cristiano Fieni, Stefania Livia Ciummo, Emma Di Carlo · 2021 · Frontiers in Immunology
Serrated Colorectal Lesions: An Up-to-Date Review from Histological Pattern to Molecular Pathogenesis
Martino Mezzapesa, Giuseppe Losurdo, Francesca Celiberto, Salvatore Rizzi, Antonio d’Amati, Domenico Piscitelli, Enzo Ierardi, Alfredo Di Leo · 2022 · International Journal of Molecular Sciences
Telomeres, telomerase and colorectal cancer
Bertorelle, Roberta · 2014 · World Journal of Gastroenterology
Influence of Race on Microsatellite Instability and CD8+ T Cell Infiltration in Colon Cancer
John M. Carethers, Bhavya Murali, Bing Yang, Ryan T. Doctolero, Akihiro Tajima, Ranor C.B. Basa, E. Julieta Smith, Monte Lee, Ryan Janke, Tina Ngo et al. · 2014 · PLoS ONE
Mucinous adenocarcinoma: A unique clinicopathological subtype in colorectal cancer
An Huang, Yong Yang, Jing-Yi Shi, Yukun Li, Jing‐Xuan Xu, Yu Qing Cheng, Jin Gu · 2021 · World Journal of Gastrointestinal Surgery
Telomerase is an independent prognostic marker of overall survival in patients with colorectal cancer
Bertorelle, R, Briarava, M, Rampazzo, E, Biasini, L, Agostini, M, Maretto, I, Lonardi, S, Friso, M L, Mescoli, C, Zagonel, V et al. · 2013 · British Journal of Cancer
Difference between right-sided and left-sided colorectal cancers: from embryology to molecular subtype
Seung Yoon Yang, Min Soo Cho, Nam Kyu Kim · 2018 · Expert Review of Anticancer Therapy
Genetic and epigenetic dependencies in colorectal cancer development
Sehej Parmar, Hariharan Easwaran · 2022 · Gastroenterology report
The prognostic factors and multiple biomarkers in young patients with colorectal cancer
Mo‐Jin Wang, Jie Ping, Yuan Li, Gunnar Adell, Gunnar Arbman, Björn Nodin, Wenjian Meng, Hong Zhang, Yongyang Yu, Cun Wang et al. · 2015 · Scientific Reports
Anthocyanins, delphinidin-3-O-glucoside and cyanidin-3-O-glucoside, inhibit immune checkpoints in human colorectal cancer cells in vitro and in silico
Candice Mazewski, Morgan Sanha Kim, Elvira González de Mejı́a · 2019 · Scientific Reports
Four Molecular Subtypes of Colorectal Cancer and Their Precursor Lesions
Gyeong Hoon Kang · 2011 · Archives of Pathology & Laboratory Medicine
Defective Mismatch Repair Status as a Prognostic Biomarker of Disease-Free Survival in Stage III Colon Cancer Patients Treated with Adjuvant FOLFOX Chemotherapy
Aziz Zaanan, Jean–François Fléjou, Jean‐François Emile, Gaëtan Des Guetz, Peggy Dartigues, David Malka, Cédric Lecaille, Pierre Validire, Christophe Louvet, Philippe R Rougier et al. · 2011 · Clinical Cancer Research
MSH3 Mediates Sensitization of Colorectal Cancer Cells to Cisplatin, Oxaliplatin, and a Poly(ADP-ribose) Polymerase Inhibitor
Masanobu Takahashi, Minoru Koi, Francesc Balaguer, Clement Richard Boland, Ajay Goel · 2011 · Journal of Biological Chemistry
G ene expression differences among different MSI statuses in colorectal cancer
Lei Chen, Xiaoyong Pan, Xiaohua Hu, Yuhang Zhang, Shaopeng Wang, Tao Huang, Yu‐Dong Cai · 2018 · International Journal of Cancer
Updated review on green tea polyphenol epigallocatechin-3-gallate as a cancer epigenetic regulator
Feng Li, Syeda Qasim, Dapeng Li, Q. Ping Dou · 2021 · Seminars in Cancer Biology
ROS homeostasis in cell fate, pathophysiology, and therapeutic interventions
Yuan-Shen Chen, Huixiang Tian, Ding‐Chao Rong, Luozixian Wang, Shan Chen, Jun Zeng, Heng Xu, Jie Mei, Lei-Yun Wang, Yu‐Ligh Liou et al. · 2025 · Molecular Biomedicine
The CpG island methylator phenotype may confer a survival benefit in patients with stage II or III colorectal carcinomas receiving fluoropyrimidine-based adjuvant chemotherapy
Byung‐Hoon Min, Jeong Mo Bae, Eui Jin Lee, Hong Suk Yu, Young‐Ho Kim, Dong Kyung Chang, Hee Cheol Kim, Cheol Keun Park, Suk-Hee Lee, Kyoung‐Mee Kim et al. · 2011 · BMC Cancer
Resolving the Paradox of Colon Cancer Through the Integration of Genetics, Immunology, and the Microbiota
Marine Fidelle, Satoru Yonekura, Marion Picard, Alexandria P. Cogdill, Antoine Hollebecque, María Paula Roberti, Laurence Zitvogel · 2020 · Frontiers in Immunology
Colorectal carcinomas with KRAS codon 12 mutation are associated with more advanced tumor stages
Wenbin Li, Tian Qiu, Wenxue Zhi, Susheng Shi, Shuangmei Zou, Yun Ling, Ling Shan, Jianming Ying, Ning Lü · 2015 · BMC Cancer
Predictive and on-treatment monitoring biomarkers in advanced melanoma: Moving toward personalized medicine
Ahmad A. Tarhini, Ragini Reiney Kudchadkar · 2018 · Cancer Treatment Reviews
The Role of Intra-Tumoral Heterogeneity and Its Clinical Relevance in Epithelial Ovarian Cancer Recurrence and Metastasis
Cai M. Roberts, Carlos Cardenas, Roslyn Tedja · 2019 · Cancers
Microsatellite instability in the management of colorectal cancer
Maria Simona Pino, Daniel C. Chung · 2011 · Expert Review of Gastroenterology & Hepatology
Comprehensive analysis of indels in whole-genome microsatellite regions and microsatellite instability across 21 cancer types
Akihiro Fujimoto, Masashi Fujita, Takanori Hasegawa, Jing Hao Wong, Kazuhiro Maejima, Aya Oku‐Sasaki, Kaoru Nakano, Yuichi Shiraishi, Satoru Miyano, Seiya Imoto et al. · 2020 · Genome Research
Mismatch repair status in patients with primary operable colorectal cancer: associations with the local and systemic tumour environment
James Hugh Park, Arfon G. M. T. Powell, Campbell S.D. Roxburgh, Paul G. Horgan, Donald C. McMillan, Joanne Edwards · 2016 · British Journal of Cancer
The clinical utility of microsatellite instability in colorectal cancer
Zhenli Diao, Yanxi Han, Yuqing Chen, Rui Zhang, Jinming Li · 2020 · Critical Reviews in Oncology/Hematology
The Role of ARID1A in Tumors: Tumor Initiation or Tumor Suppression?
Shouying Xu, Chao Tang · 2021 · Frontiers in Oncology
Lymphocytic response to tumour and deficient dna mismatch repair identify subtypes of stage ii/iii colorectal cancer associated with patient outcomes
Williams, David S, Mouradov, Dmitri, Jorissen, Robert N, Newman, Marsali R, Amini, Elham, Nickless, David K, Teague, Julie A, Fang, Catherine G, Palmieri, Michelle, Parsons, Marie J et al. · 2019 · Gut
Immunotherapy for colorectal cancer: Rational strategies and novel therapeutic progress
Farangis Rastin, Hossein Javid, Mahsa Akbari Oryani, Nastaran Rezagholinejad, Amir R. Afshari, Mehdi Karimi‐Shahri · 2023 · International Immunopharmacology
Over-expression of AURKA, SKA3 and DSN1 contributes to colorectal adenoma to carcinoma progression
Tzu-Po Chuang, Jaw‐Yuan Wang, Shu‐Wen Jao, Chang-Chieh Wu, Jiann‐Hwa Chen, Koung-Hung Hsiao, Chung‐Yen Lin, Shu‐Hwa Chen, Sheng-Yao Su, Ying‐Ju Chen et al. · 2016 · Oncotarget
High endothelial venules are rare in colorectal cancers but accumulate in extra-tumoral areas with disease progression
Diana F. Costa Bento, Emma Jones, Syed Junaid, Justyna Tull, Geraint T. Williams, Andrew J Godkin, Ann Ager, Awen Gallimore · 2015 · OncoImmunology
Cell surface proteomics identifies glucose transporter type 1 and prion protein as candidate biomarkers for colorectal adenoma-to-carcinoma progression
Meike de Wit, Connie R. Jiménez, Beatriz G. Carvalho, Jeroen A.M. Beliën, Pien M. Delis‐van Diemen, Sandra Mongera, Sander R. Piersma, Vikas C. Maindad, Sanjay Navani, Fredrik Pontén et al. · 2011 · Gut
Docosahexaenoic Acid Induces Oxidative DNA Damage and Apoptosis, and Enhances the Chemosensitivity of Cancer Cells
Eun Song, Hyeyoung Kim · 2016 · International Journal of Molecular Sciences
Friend or foe?
Tommaso Colangelo, Giovanna Polcaro, Livio Muccillo, Giovanna D'Agostino, Valeria Rosato, Pamela Ziccardi, Angelo Lupo, Gianluigi Mazzoccoli, Lina Sabatino, Vittorio Colantuoni · 2016 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Clinical Trials and Progress in Metastatic Colon Cancer
Kabir Mody, Tanios Bekaii‐Saab · 2018 · Surgical Oncology Clinics of North America
γδ T cell dichotomy with opposing cytotoxic and wound healing functions in human solid tumors
Cathal Harmon, Alexandra M. Zaborowski, Haim Moore, Pamela St. Louis, Karen Slattery, Danielle Duquette, John Scanlan, Harry Kane, Britta H. Kunkemoeller, Claire McIntyre et al. · 2023 · Nature Cancer
Interrelationship between microsatellite instability and microRNA in gastrointestinal cancer
Hiroyuki Yamamoto · 2012 · World Journal of Gastroenterology
Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series
Enric Domingo, Carme Camps, Pamela J. Kaisaki, Marie J. Parsons, Dmitri Mouradov, Melissa M. Pentony, Seiko Makino, Michelle Palmieri, Robyn Lynne Ward, Nicholas John Hawkins et al. · 2018 · The Lancet. Gastroenterology & hepatology
SHP2 deneddylation mediates tumor immunosuppression in colon cancer via the CD47/SIRPα axis
Yiqing Li, Hui Zhou, Pan Liu, Dandan Lv, Yichun Shi, Bufu Tang, Jiaqi Xu, Tingting Zhong, Wangting Xu, Jie Zhang et al. · 2023 · Journal of Clinical Investigation
Long interspersed nuclear element‐1 hypomethylation is a potential biomarker for the prediction of response to oral fluoropyrimidines in microsatellite stable and CpG island methylator phenotype‐negative colorectal cancer
Kazuyuki Kawakami, Aika Matsunoki, Mami Kaneko, Kenichiro Saito, Go Watanabe, Toshinari Minamoto · 2010 · Cancer Science
Colorectal cancer: epigenetic alterations and their clinical implications
Alberto Puccini, Martin D. Berger, Madiha Naseem, Ryuma Tokunaga, Francesca Battaglin, Shu Cao, Diana L. Hanna, Michelle McSkane, Shivani Soni, Wu Zhang et al. · 2017 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Reconciliation of classification systems defining molecular subtypes of colorectal cancer
Anguraj Sadanandam, Xin Wang, Felipe de Sousa e Melo, Joe W. Gray, Louis Vermeulen, Douglas Hanahan, Jan Paul Medema · 2014 · Cell Cycle
Mutations in DNA repair genes are associated with increased neoantigen burden and a distinct immunophenotype in lung squamous cell carcinoma
Young Kwang Chae, Jonathan Forrest Anker, Michael S. Oh, Preeti Bais, Sandeep Namburi, Sarita Agte, Francis Joseph Giles, Jeffrey H. Chuang · 2019 · Scientific Reports
The landscape of genomic copy number alterations in colorectal cancer and their consequences on gene expression levels and disease outcome
Thomas Ried, Gerrit A. Meijer, David James Harrison, Godfrey Grech, Sebastià Franch‐Expósito, Romina Briffa, Beatriz G. Carvalho, Jordi Camps · 2019 · Molecular Aspects of Medicine
The Cytokine Network in Colorectal Cancer: Implications for New Treatment Strategies
Heidi Braumüller, Bernhard Mauerer, Johanna Andris, Christopher Berlin, Thomas Wieder, Rebecca Kesselring · 2022 · Cells
Identification of Candidate Oncogenes in Human Colorectal Cancers With Microsatellite Instability
Alexandra E. Gylfe, Johanna Kondelin, Mikko M. Turunen, Heikki Ristolainen, Riku Katainen, Esa Pitkänen, Eevi Kaasinen, Ville Rantanen, Tomas J. Tanskanen, Markku T Varjosalo et al. · 2013 · Gastroenterology
The impact of anti-inflammatory agents on the outcome of patients with colorectal cancer
James Hugh Park, Donald C. McMillan, Paul G. Horgan, Campbell S.D. Roxburgh · 2013 · Cancer Treatment Reviews
Prevalence of Loss of Expression of DNA Mismatch Repair Proteins in Primary Epithelial Ovarian Tumors
Fang‐I Lu, C. Blake Gilks, Anna Marie Mulligan, Paul MacDaragh Ryan, Ghassan Allo, Keiyan Sy, Particia A. Shaw, Aaron F. Pollett, Blaise Alexander Clarke · 2012 · International Journal of Gynecological Pathology
Alterations in PTEN and PIK3CA in colorectal cancers in the EPIC Norfolk study: associations with clinicopathological and dietary factors
Adam Naguib, James C. Cooke, Lisa C. Happerfield, Lucy Kerr, Laura J. Gay, Robert Luben, Richard Y. Ball, Panagiota N. Mitrou, Alison McTaggart, Mark Johan Arends · 2011 · BMC Cancer
Comprehensive analysis of CpG island methylator phenotype (CIMP)‐high, ‐low, and ‐negative colorectal cancers based on protein marker expression and molecular features
Inti Zlobec, Michel Bihl, Anja Foerster, Alexander Rufle, Alessandro Lugli · 2011 · The Journal of Pathology
Association between Fusobacterium nucleatum and colorectal cancer: Progress and future directions
S. Zhang, Sanjun Cai, Yanlei Ma · 2018 · Journal of Cancer
The molecular biology of colorectal carcinoma and its implications: A review
Sanjay Harrison, Harrison Benziger · 2011 · The Surgeon
A tailored approach to BRAF and MLH1 methylation testing in a universal screening program for Lynch syndrome
Tomer Adar, Linda Rodgers, Kristen Mahoney Shannon, Makoto Yoshida, Tianle Ma, Anthony R. Mattia, Gregory Yves Lauwers, Anthony John Iafrate, Daniel C. Chung · 2017 · Modern Pathology
Integrative Marker Analysis Allows Risk Assessment for Metastasis in Stage II Colon Cancer
Ulrich Nitsche, Robert Rosenberg, Alexander Balmert, Tibor Schuster, Julia Slotta‐Huspenina, Pia Herrmann, Franz G. Bader, Helmut Friess, Peter Michael Schlag, Ulrike Stein et al. · 2012 · Annals of Surgery
Screening for Lynch Syndrome by Immunohistochemistry of Mismatch Repair Proteins: Significance of Indeterminate Result and Correlation With Mutational Studies
Venetia Rumnong Sarode, Linda D. Robinson · 2019 · Archives of Pathology & Laboratory Medicine
Latest evidence on immune checkpoint inhibitors in metastatic colorectal cancer: A 2022 update
Aristeidis E. Boukouris, Maria Theochari, Dimitra T. Stefanou, Alexandros Papalambros, Evangelos S. Felekouras, Helen J Gogas, Dimitrios C. Ziogas · 2022 · Critical Reviews in Oncology/Hematology
MLH1‐silenced and non‐silenced subgroups of hypermutated colorectal carcinomas have distinct mutational landscapes
Lawrence A. Donehower, Chad J. Creighton, Nikolaus D. Schultz, Eve Shinbrot, Kyle Chang, Preethi H. Gunaratne, Donna Marie Muzny, Chris Sander, Stanley R. Hamilton, Richard A. Gibbs et al. · 2012 · The Journal of Pathology
Expression of the MAP kinase phosphatase DUSP4 is associated with microsatellite instability in colorectal cancer (CRC) and causes increased cell proliferation
Benedikt Gröschl, Marcus Bettstetter, Christian Giedl, Matthias Woenckhaus, Tina Bocker Edmonston, Ferdinand Hofstädter, Wolfgang Dietmaier · 2012 · International Journal of Cancer
Mesenchymal stromal cells (MSCs) and colorectal cancer: a troublesome twosome for the anti-tumour immune response?
Grace O’Malley, Madelon T. Heijltjes, Aileen M. Houston, Sweta Rani, Thomas Ritter, Laurence John Egan, Aideen E. Ryan · 2016 · Oncotarget
The Cumulative Effects of Polymorphisms in the DNA Mismatch Repair Genes and Tobacco Smoking in Oesophageal Cancer Risk
Matjaž Vogelsang, Yabing Wang, Nika Veber, Lamech Malagho Mwapagha, Mohamed Iqbal Parker · 2012 · PLoS ONE